Overview

An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Eisai Inc.
Collaborator:
Eisai Limited